Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases

Journal of the National Cancer Institute

Volumn 91, Issue 17, 1999, Pages 1468-1474

  Rezza, Giovanni ^a   Andreoni, Massimo ^b   Dorrucci, Maria ^a   Pezzotti, Patrizio ^a   Monini, Paolo ^a   Zerboni, Roberto ^h   Salassa, Benardino ^c   Colangeli, Vincenzo ^h   Sarmati, Loredana ^b   Nicastri, Emanuele ^b   Barbanera, Mauro ^d   Pristerà, Raffaele ^e   Aiuti, Fernando ^f   Ortona, Luigi ^g   Ensoli, Barbara ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c AMEDEO DI SAVOIA HOSPITAL   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e Ospedale Regionale   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CANCER GROWTH; CANCER RISK; DISEASE COURSE; FEMALE; HELPER CELL; HOMOSEXUALITY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROCONVERSION; SEROLOGY; VIRUS CARCINOGENESIS;

EID: 0033199819     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.17.1468     Document Type: Article

References (40)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-9.
2. Ambroziak JA, Blackbourn DJ, Herndier BG, Glogau RG, Gullettt JH, McDonald AR, et al. Herpesvirus-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients [letter]. Science 1995;268:582-3.
3. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma patients with and those without HIV infection. N Engl J Med 1995;332:1181-5.
4. Schalling M, Ekman M, Kaaia EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995;1:707-8.
5. Chuck S, Grant RM, Katongole-Mbidde E, Conant M, Ganem D. Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis 1996;173:248-51.
6. Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995;345:759-61.
7. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, el al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
8. Cesarman E, Chang Y, Moore PS, Sald JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995;332:1186-91.
9. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
10. Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996;10: 175-80.
11. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcomaassociated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission [published erratum appears in Nat Med 1996;2:1041]. Nat Med 1996;2:918-24.
12. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61.
13. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335:233-41.
14. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med 1998; 338:948-54.
15. Renwick N, Halaby T, Weverling GJ, Dukers NH, Simpson GR, Coutinho RA, et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 1998;12:2481-8.
16. Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, et al. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996. Int J Cancer 1998;77:543-8.
17. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group. Arch Intern Med 1994;154:566-72.
18. Rezza G, Lazzarin A, Angarano G, Sinicco A, Pristera R, Ortona L, et al. The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters. AIDS 1989;3:87-90.
19. The Italian Seroconversion Study. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. AIDS 1992;6:421-6.
20. Council of State and Territorial Epidemiologists, AIDS Program, Center for Infectious Diseases. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987;36 Suppl 1:1S-15S.
21. Andreoni M, El-Sawat G, Rezza G, Ensoli B, Nicastri E, Ventura L, et al. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst 1999;91: 465-9.
22. Monini P, Carlini F, Sturzl M, Rimessi P, Superti F, Franco M, et al. α-Interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol 1999;73:4029-41.
23. Ancelle-Park R. Expanded European AIDS case definition [letter]. Lancet 1993;341:441.
24. Lee ET. Statistical methods for survival data analysis. New York (NY): John Wiley & Sons; 1992.
25. Kedes DH, Ganem D. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 1997;99:2082-6.
26. Medveczky MM, Horvath E, Lund T, Medveczky PG. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 1997;11:1327-32.
27. Lefrere JJ, Meyohas MC, Mariotti M, Meynard JL, Thauvin M, Frottier J. Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. J Infect Dis 1996;174:283-7.
28. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2:925-8.
29. Smith MS, Bloomer C, Horvat R, Goldstein E, Casparian JM, Chandran B. Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 1997;176:84-93.
30. Karcher DS, Alkan S. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease [letter]. N Engl J Med 1995;333: 797-8.
31. Gaidano G, Pastore C, Gloghini A, Cusini M, Nomdedeu J, Volpe G, et al. Distribution of human herpesvirus-8 sequences throughout the spectrum of AIDS-related neoplasia. AIDS 1996;10:941-9.
32. Veugelers PJ, Strathdee SA, Tindall B, Page KA, Moss AR, Schlechter MT, et al. Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-infected homosexual men. AIDS 1994;8: 1471-5.
33. Phillips AN, Lazzarin A, Gonzales-Lahoz J, Clumeck N, Glauser MP, Proenca R, et al. Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study Group. J Clin Epidemiol 1996;49: 1253-8.
34. Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996;124: 633-42.
35. Costagliola D, Mary-Krause M. Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodeficience Humaine [letter]. Lancet 1995;346:578.
36. Glesby MJ, Hoover DR, Weng S, Graham NM, Phair JP, Detels R, et al. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis 1996;173:1477-80.
37. Humphrey RW, O'Brien TR, Newcomb FM, Nishihara H, Wyvill KM, Ramos GA, et al. Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs. Blood 1996;88:297-301.
38. Morfeldt L, Torssander J. Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients. Scand J Infect Dis 1994;26:749-52.
39. Jones JL, Hanson DL, Chu SY, Ward JW, Jaffe HW. AIDS-associated Kaposi's sarcoma [letter]. Science 1995;267:1078-9.
40. Mocroft A, Youle M, Gazzard B, Morcinek J, Halai R, Phillips AN. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. AIDS 1996;10: 1101-5.